CHAMPION: Combining HIV And Meth Prevention and Treatment Interventions Optimized for HIV-Negative MSM
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Diego
- Study ID
- NCT07213258
- Status
- Recruiting
Conditions
- HIV
- Methamphetamine Use Disorder
- PrEP Adherence
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - 40 Years
- Healthy Volunteers
- Not accepted
Interventions
- CHAMPION Intervention — BEHAVIORALMHealth intervention to enhance PrEP adherence, combined with computer-administered cognitive behavioral therapy for a 6-month period for the intervention arm.
- Delayed CHAMPION Package — BEHAVIORALInformational resources for first 3-months of study, followed by CHAMPION intervention for final 3-months.
Study Details
The goal of this randomized controlled trial is to pilot test new mobile health (mHealth) interventions to improve PrEP adherence among HIV-negative men who have sex with men (MSM) with mild to moderate methamphetamine use disorder (MUD). The CHAMPION intervention combines two mHealth tools-PrEPAPP and CBT4CBT-to address both HIV prevention and MUD treatment needs in this population. The study's specific aims are: * To evaluate the feasibility and acceptability of the CHAMPION intervention based on treatment retention and engagement rates. * To examine the preliminary efficacy the CHAMPION intervention to improve PrEP adherence, as measured by dried blood spot (DBS) tests compared to the waitlist control group.
Key Dates
- First listed
- Oct 8, 2025
- Start date
- Apr 24, 2026
- Status verified
- Aug 2026
- Primary completion
- Jul 31, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: CHAMPION Intervention ArmmHealth app to track and promote PrEP adherence using motivational messages combined with computer-administered cognitive behavioral therapy for the full 6-month period.
- Other: Waitlist Control Arm3-month waitlist period including informational resources, followed by 3-month CHAMPION intervention.
Primary Outcome Measure
Feasibility & Acceptability of CHAMPION [ Time Frame: 6 months ]
Central Contacts
- Glenn-Milo Santos, PhD, MPH628-217-6231
- Alexandrea Dunham, B.A.530-925-3398
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Center on Substance Use and Health | San Francisco | California | 94102 |
Find similar trials in San Francisco, CA
Related Studies
- The Use of Leukapheresis to Support HIV Pathogenesis StudiesRecruiting · University of California, San Francisco · San Francisco, California
- The Use of Lymph Node Biopsies to Support HIV Pathogenesis StudiesRecruiting · University of California, San Francisco · San Francisco, California
- Collection of Blood for Multiple Collaborative StudiesRecruiting · University of California, San Francisco · San Francisco, California
- Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV CareRecruiting · Johns Hopkins University · San Diego, California